CMA welcomes B3-skin cancer findings

CEO of Complementary Medicines Australia Carl Gibson has welcomed results from a University of Sydney study, published in the New England Journal of Medicine, which show that vitamin B3 (nicotinamide) can cut the risk of new skin cancers by 23%. In this double-blind, randomised, controlled trial, participants who had, in the last five years, had